We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Would Ease Postmarket Burdens to Move Quality by Design
FDA Would Ease Postmarket Burdens to Move Quality by Design
October 13, 2006
The FDA is taking steps to introduce more regulatory flexibility into postmarket reviews in order to get industry’s support for the agency’s Quality by Design (QbD) initiative, officials said.